Unknown

Dataset Information

0

C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b/Akt pathway.


ABSTRACT:

Background

The increased bone marrow angiogenesis is involved in the progression of multiple myeloma (MM) with the underlying mechanism poorly understood. Cancer-released exosomes could play an important role in the pathological angiogenesis through exosomal microRNAs (miRs) delivery. It is reported that miR-29b played an important role in regulating the tumor angiogenesis.

Methods

In this study, we explored the role of C6-ceramide (C6-cer, a Ceramide pathway activator) in the angiogenic effect of MM exosomes and its potential mechanism. MM cells (OPM2 and RPMI-8226) treated with C6-cer were studied for its effects on the endothelial cell (EC) functions.

Results

Our results showed that exosomes released from MM cells treated by C6-cer (ExoC6-cer) significantly inhibited the proliferation, migration and tube formation of ECs. For mechanism studies, we found that the level of miR-29b was increased in ECs treated by ExoC6-cer, while mRNA and protein expressions of Akt3, PI3K and VEGFA were decreased in ECs, indicating the involvement of Akt pathway. Furthermore, downregulation of miR-29b by inhibitor administration could prevent the ExoC6-cer-induced cell proliferation, migration and angiogenesis of ECs, accompanied with the increased expressions of Akt3, PI3K and VEGFA.

Conclusions

Collectively, our data suggest that ExoC6-cer-mediated miR-29b expression participates in the progression of MM through suppressing the proliferation, migration and angiogenesis of ECs by targeting Akt signal pathway.

SUBMITTER: Liu L 

PROVIDER: S-EPMC7398185 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b/Akt pathway.

Liu Liping L   Ye Qinmao Q   Liu Langni L   Bihl Ji Chen JC   Chen Yanfang Y   Liu Jing J   Cheng Qian Q  

Journal of translational medicine 20200803 1


<h4>Background</h4>The increased bone marrow angiogenesis is involved in the progression of multiple myeloma (MM) with the underlying mechanism poorly understood. Cancer-released exosomes could play an important role in the pathological angiogenesis through exosomal microRNAs (miRs) delivery. It is reported that miR-29b played an important role in regulating the tumor angiogenesis.<h4>Methods</h4>In this study, we explored the role of C6-ceramide (C6-cer, a Ceramide pathway activator) in the ang  ...[more]

Similar Datasets

| S-EPMC3717964 | biostudies-literature
| S-EPMC5886056 | biostudies-literature
| S-EPMC5470968 | biostudies-literature
| S-EPMC6030427 | biostudies-literature
| S-EPMC6365572 | biostudies-literature
| S-EPMC5727805 | biostudies-literature
2018-10-10 | GSE104831 | GEO
| S-EPMC3903716 | biostudies-literature
| S-EPMC5542180 | biostudies-other
| S-EPMC5458521 | biostudies-literature